FI107928B - Erityskuljetin hirudiinin tai hirudiinianalogin tuottamiseksi, kyseessä olevan kuljettimen sisältävät muutetut mikro-organismit, sekä hirudiinin tai hirudiinianalogin valmistusmenetelmä - Google Patents

Erityskuljetin hirudiinin tai hirudiinianalogin tuottamiseksi, kyseessä olevan kuljettimen sisältävät muutetut mikro-organismit, sekä hirudiinin tai hirudiinianalogin valmistusmenetelmä Download PDF

Info

Publication number
FI107928B
FI107928B FI922963A FI922963A FI107928B FI 107928 B FI107928 B FI 107928B FI 922963 A FI922963 A FI 922963A FI 922963 A FI922963 A FI 922963A FI 107928 B FI107928 B FI 107928B
Authority
FI
Finland
Prior art keywords
hirudin
plasmid
gly
dna
analogue
Prior art date
Application number
FI922963A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922963A0 (fi
FI922963A (fi
Inventor
Saturo Misawa
Hitoshi Matsuda
Yoshifumi Inoue
Hideyuki Furuya
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2303096A external-priority patent/JPH07119237B2/ja
Priority claimed from JP4127191A external-priority patent/JP3226289B2/ja
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of FI922963A0 publication Critical patent/FI922963A0/fi
Publication of FI922963A publication Critical patent/FI922963A/fi
Application granted granted Critical
Publication of FI107928B publication Critical patent/FI107928B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
FI922963A 1990-11-08 1992-06-26 Erityskuljetin hirudiinin tai hirudiinianalogin tuottamiseksi, kyseessä olevan kuljettimen sisältävät muutetut mikro-organismit, sekä hirudiinin tai hirudiinianalogin valmistusmenetelmä FI107928B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2303096A JPH07119237B2 (ja) 1990-11-08 1990-11-08 ヒルジン変異体，その製造法及び抗凝血剤
JP30309690 1990-11-08
JP4127191A JP3226289B2 (ja) 1991-02-13 1991-02-13 分泌ベクター、該ベクターで形質転換した微生物及び該微生物から産生される産物の製造法
JP4127191 1991-02-13
JP9101533 1991-11-08
PCT/JP1991/001533 WO1992008736A1 (fr) 1990-11-08 1991-11-08 Mutant d'hirudine, sa production, anticoagulant, vecteur secretoire, microorganisme transforme par ledit vecteur et production d'un produit a partir dudit microorganisme

Publications (3)

Publication Number Publication Date
FI922963A0 FI922963A0 (fi) 1992-06-26
FI922963A FI922963A (fi) 1992-06-26
FI107928B true FI107928B (fi) 2001-10-31

Family

ID=26380836

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922963A FI107928B (fi) 1990-11-08 1992-06-26 Erityskuljetin hirudiinin tai hirudiinianalogin tuottamiseksi, kyseessä olevan kuljettimen sisältävät muutetut mikro-organismit, sekä hirudiinin tai hirudiinianalogin valmistusmenetelmä

Country Status (12)

Country Link
US (2) US5516656A (fr)
EP (2) EP0511393B1 (fr)
AT (2) ATE176500T1 (fr)
AU (2) AU648124B2 (fr)
CA (2) CA2255396A1 (fr)
DE (2) DE69130872T2 (fr)
DK (2) DK0687731T3 (fr)
ES (2) ES2129749T3 (fr)
FI (1) FI107928B (fr)
GR (2) GR3021410T3 (fr)
NO (2) NO303735B1 (fr)
WO (1) WO1992008736A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341414C (fr) * 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
US5972648A (en) * 1993-09-28 1999-10-26 Japan Energy Corporation Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
RU2182598C2 (ru) * 1994-11-21 2002-05-20 Новартис Аг Модифицированные ингибиторы протеиназы
DE19944870A1 (de) 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
DE10108211A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen
DE10108212A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
CN100532557C (zh) 2002-08-23 2009-08-26 纳幕尔杜邦公司 淀粉制品在利用发酵的生物生产中的应用
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
ATE480561T1 (de) 2004-10-19 2010-09-15 Lonza Ag Verfahren zur festphasen-peptidsynthese
DK1903115T3 (da) * 2006-09-22 2011-05-23 Wacker Chemie Ag Fremgangsmåde til fermentativ fremstilling af antistoffer
CN101372512B (zh) * 2007-08-23 2011-03-23 中国人民解放军军事医学科学院生物工程研究所 一类抗凝血多肽及其用途
WO2010054503A1 (fr) * 2008-11-17 2010-05-20 中国人民解放军军事医学科学院生物工程研究所 Polypeptides anticoagulants et leurs applications
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562088B1 (fr) * 1984-03-27 1987-11-13 Transgene Sa Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
ATE78515T1 (de) * 1984-10-05 1992-08-15 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
JP2518862B2 (ja) * 1987-08-31 1996-07-31 株式会社蛋白工学研究所 新規プラスミドベクタ―
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
AU614121B2 (en) 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
JPH0648988B2 (ja) 1988-07-26 1994-06-29 工業技術院長 トロンビン阻害物質の製造法
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
JPH0292288A (ja) * 1988-09-30 1990-04-03 Japan Tobacco Inc アクアライシンｉ前駆体をコードする遺伝子、それを含む発現ベクター、該発現ベクターを含む大腸菌及びそれを用いたアクアライシンｉの製造方法
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
IE902877A1 (en) * 1989-08-10 1991-02-27 Japan Energy Corp Expression vector for hirudin, hirudin fusion protein,¹transformed microorganism and method for production of¹hirudin
JPH03164184A (ja) 1989-08-10 1991-07-16 Nippon Mining Co Ltd ヒルジン発現ベクター、ヒルジン融合蛋白、形質転換微生物及びヒルジンの製造法
JPH0376579A (ja) 1989-08-18 1991-04-02 Nippon Mining Co Ltd ヒト‐アンジオジェニン発現ベクター及びヒト‐アンジオジェニンの製造方法
GB9010552D0 (en) * 1990-05-10 1990-07-04 Erba Carlo Spa Method for the recombinant production of hirudins and novel hirudins

Also Published As

Publication number Publication date
EP0687731A1 (fr) 1995-12-20
WO1992008736A1 (fr) 1992-05-29
ES2129749T3 (es) 1999-06-16
GR3029824T3 (en) 1999-06-30
ES2093717T3 (es) 1997-01-01
FI922963A0 (fi) 1992-06-26
US5573929A (en) 1996-11-12
DK0511393T3 (da) 1996-12-09
FI922963A (fi) 1992-06-26
NO982207L (no) 1992-09-07
CA2072375A1 (fr) 1992-05-09
CA2072375C (fr) 2000-01-11
ATE140929T1 (de) 1996-08-15
ATE176500T1 (de) 1999-02-15
DK0687731T3 (da) 1999-09-20
EP0511393B1 (fr) 1996-07-31
DE69121192D1 (de) 1996-09-05
AU5470194A (en) 1994-03-24
NO982207D0 (no) 1998-05-14
EP0511393A1 (fr) 1992-11-04
DE69130872D1 (de) 1999-03-18
AU8846691A (en) 1992-06-11
US5516656A (en) 1996-05-14
DE69121192T2 (de) 1997-02-20
CA2255396A1 (fr) 1992-05-09
NO303735B1 (no) 1998-08-24
EP0511393A4 (en) 1993-08-11
NO922671L (no) 1992-09-07
DE69130872T2 (de) 1999-08-26
EP0687731B1 (fr) 1999-02-03
AU648124B2 (en) 1994-04-14
NO922671D0 (no) 1992-07-07
GR3021410T3 (en) 1997-01-31
AU673870B2 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
FI107928B (fi) Erityskuljetin hirudiinin tai hirudiinianalogin tuottamiseksi, kyseessä olevan kuljettimen sisältävät muutetut mikro-organismit, sekä hirudiinin tai hirudiinianalogin valmistusmenetelmä
US5631144A (en) Application of novel DNA fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeast and corresponding process for the preparation of proteins
US5227293A (en) Fusion proteins, their preparation and use
FI104635B (fi) Hirudiinia tuottava transformoitu hiiva ja menetelmä hirudiinin valmistamiseksi sillä
KR0156246B1 (ko) 프로테이나제 억제제, 그의 제조방법 및 그를 함유한 의약
FI100250B (fi) Hirudiinijohdannaisten eritys
JPH07507995A (ja) トロンビンレセプターアンタゴニスト
FI99211C (fi) Menetelmä hirudiinivariantin valmistamiseksi
EP0362259B1 (fr) Procede de production de cystatine c ou modifications de la cystatine et sequence d'adn destinee a etre utilisee lors de la realisation dudit procede
AU661515B2 (en) Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
JPH10505502A (ja) 修飾されたコラーゲン誘導血小板凝集阻害剤パリジピンの製法
AU685835B2 (en) High molecular weight desulphatohirudin
FI96116B (fi) Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi
JP2798573B2 (ja) ヒト好中球エラスターゼ阻害活性を有する天然型ポリペプチドおよびそれを含有する医薬製剤
JPH07119237B2 (ja) ヒルジン変異体，その製造法及び抗凝血剤
JP3226289B2 (ja) 分泌ベクター、該ベクターで形質転換した微生物及び該微生物から産生される産物の製造法
RU2106408C1 (ru) Аналог гирудина, днк, вектор, способ получения аналога гирудина
RU2130071C1 (ru) Вектор секреции для получения гирудина hv1 (варианты), рекомбинантный штамм escherichia coli - продуцент гирудина hv1 и способ его получения
RU2104305C1 (ru) Аналоги инсулина человека, способ их получения, раствор для инъекций
EP0625580A1 (fr) Nouvelle variante d'hirudine, son procede de production, et anticoagulant la contenant comme ingredient actif
PT100299B (pt) Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos
JPH07196688A (ja) 新規な生理活性ポリペプチド、その製造方法及び用途
GB2242681A (en) Hirudin fragments
JPH03506039A (ja) 転移防止性ペプチド

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: JAPAN ENERGY CORPORATION